Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$43.15 USD
-0.69 (-1.57%)
Updated May 10, 2024 04:00 PM ET
After-Market: $43.14 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.72 | -7.82% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.69 per share. This reflects a positive earnings surprise of 14.49%. Look out for HALO's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.72 per share, reflecting a year-over-year decrease of 2.7%.
Earnings History
Price & Consensus
Zacks News for HALO
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services